Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?

Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research

(2021) Valentina Franco et al.   NEUROPHARMACOLOGY

Cannabinoids, Phenolics, Terpenes and Alkaloids of Cannabis

(2021) Mohamed M. Radwan et al.   MOLECULES

Understanding the complex pharmacology of cannabidiol: Mounting evidence suggests a common binding site with cholesterol

(2021) Lewis J. Martin et al.   PHARMACOLOGICAL RESEARCH

Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum

(2021) João F.C. Pedrazzi et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer’s Disease and Diabetes

(2021) Gabriela Dumitrita Stanciu et al.   Biomedicines

Cannabidiol in the prelimbic cortex modulates the comorbid condition between the chronic neuropathic pain and depression-like behaviour in rats: The role of medial prefrontal cortex 5-HT1A and CB1 receptors

(2021) R.B. Malvestio et al.   BRAIN RESEARCH BULLETIN

Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats

(2021) Vinícia Garzella Metz et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The Impact of Early Life Exposure to Cannabis: The Role of the Endocannabinoid System

(2021) Annia A. Martínez-Peña et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Effects of Cannabidiol on the In Vitro Lymphocyte Pro-Inflammatory Cytokine Production of Senior Horses

(2021) Shelley Turner et al.   JOURNAL OF EQUINE VETERINARY SCIENCE

Cannabidiol enhances verbal episodic memory in healthy young participants: A randomized clinical trial

(2021) Janine Hotz et al.   JOURNAL OF PSYCHIATRIC RESEARCH

An evaluation of the anti‐hyperalgesic effects of cannabidiolic acid‐methyl ester (CBDA‐ME) in a preclinical model of peripheral neuropathic pain

(2020) Yong Fang Zhu et al.   BRITISH JOURNAL OF PHARMACOLOGY

Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy

(2020) Bogdan Ionel Tamba et al.   Medicina-Lithuania

Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome

(2020) Ian Miller et al.   JAMA Neurology

Uncovering the Hidden Antibiotic Potential of Cannabis

(2020) Maya A. Farha et al.   ACS Infectious Diseases

Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors

(2020) Gemma Navarro et al.   PHARMACOLOGICAL RESEARCH

Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews

(2020) Erin M. Rock et al.   PSYCHOPHARMACOLOGY

Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products

(2020) Dongchen An et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Maternal exposure to Δ9-tetrahydrocannabinol impairs female offspring glucose homeostasis and endocrine pancreatic development in the rat

(2020) Ryan Gillies et al.   REPRODUCTIVE TOXICOLOGY

Calcium-Permeable AMPA Receptors Promote Endocannabinoid Signaling at Parvalbumin Interneuron Synapses in the Nucleus Accumbens Core

(2020) Kevin M. Manz et al.   Cell Reports

Administration of Δ9‐Tetrahydrocannabinol (THC) Post‐Staphylococcal Enterotoxin B Exposure Protects Mice From Acute Respiratory Distress Syndrome and Toxicity

(2020) Amira Mohammed et al.   Frontiers in Pharmacology

Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular Damages

(2020) Gabriela Dumitrita Stanciu et al.   Journal of Clinical Medicine

Involvement of dopamine receptor in the actions of non-psychoactive phytocannabinoids

(2020) Sarah H. Shrader et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cannabidiol Products: Review of the Regulatory and Clinical Considerations

(2020) Emily M. Hawes et al.   JNP-Journal for Nurse Practitioners

Gene Expression of Transient Receptor Potential Channels in Peripheral Blood Mononuclear Cells of Inflammatory Bowel Disease Patients

(2020) Taku Morita et al.   Journal of Clinical Medicine

Renal Contributions in the Pathophysiology and Neuropathological Substrates Shared by Chronic Kidney Disease and Alzheimer’s Disease

(2020) Gabriela Dumitrita Stanciu et al.   Brain Sciences

In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa

(2020) Ayat Zagzoog et al.   Scientific Reports

Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration

(2019) José Aguareles et al.   Translational Neurodegeneration

Identification and characterization of phytocannabinoids as novel dual PPARα/γ agonists by a computational and in vitro experimental approach

(2019) Enrico D'Aniello et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice

(2019) Erica Zamberletti et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment

(2019) Marika Premoli et al.   LIFE SCIENCES

Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer’s Disease

(2019) David Schubert et al.   MOLECULAR NEUROBIOLOGY

Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy

(2019) Valentina Franco et al.   DRUGS

Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease

(2019) Sonia Burgaz et al.   MOLECULES

Clinicians’ Guide to Cannabidiol and Hemp Oils

(2019) Harrison J. VanDolah et al.   MAYO CLINIC PROCEEDINGS

The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients

(2019) E. Pagano et al.   PHARMACOLOGICAL RESEARCH

Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats

(2019) Erica Zamberletti et al.   Frontiers in Cellular Neuroscience

Pharmacokinetics of Phytocannabinoid Acids and Anticonvulsant Effect of Cannabidiolic Acid in a Mouse Model of Dravet Syndrome

(2019) Lyndsey L. Anderson et al.   JOURNAL OF NATURAL PRODUCTS

Effects of cannabidivarin (CBDV) on brain excitation and inhibition systems in adults with and without Autism Spectrum Disorder (ASD): a single dose trial during magnetic resonance spectroscopy

(2019) Charlotte M Pretzsch et al.   Translational Psychiatry

Inflammation, Cancer and Immunity—Implication of TRPV1 Channel

(2019) Joanna Katarzyna Bujak et al.   Frontiers in Oncology

Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity

(2019) Belén Palomares et al.   BIOCHEMICAL PHARMACOLOGY

Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol

(2019) Pasquale Linciano et al.   JOURNAL OF NATURAL PRODUCTS

Cannabinoids and the expanded endocannabinoid system in neurological disorders

(2019) Luigia Cristino et al.   Nature Reviews Neurology

GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol

(2018) Alyssa S. Laun et al.   ACTA PHARMACOLOGICA SINICA

Acute oral cannabidiolic acid methyl ester reduces depression-like behavior in two genetic animal models of depression

(2018) D. Hen-Shoval et al.   BEHAVIOURAL BRAIN RESEARCH

Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model

(2018) Archie A Khan et al.   BRITISH JOURNAL OF PHARMACOLOGY

Endocannabinoid system, Stress and HPA axis

(2018) Vincenzo Micale et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol

(2018) Antonella Smeriglio et al.   FITOTERAPIA

In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid

(2018) Agnese Gugliandolo et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System

(2018) et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor

(2018) Concepción García et al.   Journal of Neuroinflammation

Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

(2018) Orrin Devinsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain

(2018) Marc P. Baggelaar et al.   PROGRESS IN LIPID RESEARCH

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes

(2018) Gemma Navarro et al.   Frontiers in Pharmacology

Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1 G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis

(2018) Carmen Rodríguez-Cueto et al.   BIOCHEMICAL PHARMACOLOGY

Iodine-mediated cyclization of cannabigerol (CBG) expands the cannabinoid biological and chemical space

(2018) Annalisa Lopatriello et al.   BIOORGANIC & MEDICINAL CHEMISTRY

The Potential Therapeutic Effects of THC on Alzheimer's Disease

(2018) Chuanhai Cao et al.   JOURNAL OF ALZHEIMERS DISEASE

Anticonvulsant and Neuroprotective Effects of Cannabidiol During the Juvenile Period

(2018) Linda K Friedman et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

New approaches and challenges to targeting the endocannabinoid system

(2018) Vincenzo Di Marzo   NATURE REVIEWS DRUG DISCOVERY

Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome

(2018) Daniele Vigli et al.   NEUROPHARMACOLOGY

Effect of cannabidiolic acid and ∆9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain

(2018) Erin M. Rock et al.   PSYCHOPHARMACOLOGY

Cannabis for cancer – illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology

(2018) Ilit Turgeman et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

The endocannabinoid system: Overview of an emerging multi-faceted therapeutic target

(2018) Dipanjan Chanda et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Effects of cannabidiol in males and females in two different rat models of depression

(2018) Liat Shbiro et al.   PHYSIOLOGY & BEHAVIOR

Engineering yeasts as platform organisms for cannabinoid biosynthesis

(2017) Bastian Zirpel et al.   JOURNAL OF BIOTECHNOLOGY

Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol

(2017) Douglas L Boggs et al.   NEUROPSYCHOPHARMACOLOGY

The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain

(2017) Giulia Donvito et al.   NEUROPSYCHOPHARMACOLOGY

Delta-9-Tetrahydrocannabinol (∆9-THC) Induce Neurogenesis and Improve Cognitive Performances of Male Sprague Dawley Rats

(2017) Noor Azuin Suliman et al.   NEUROTOXICITY RESEARCH

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

(2017) Orrin Devinsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome

(2017) Joshua S. Kaplan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Crystal Structure of the Human Cannabinoid Receptor CB 1

(2016) Tian Hua et al.   CELL

Phytocannabinoids: a unified critical inventory

(2016) Lumír Ondřej Hanuš et al.   NATURAL PRODUCT REPORTS

A cannabinoid link between mitochondria and memory

(2016) Etienne Hebert-Chatelain et al.   NATURE

Keep off the grass? Cannabis, cognition and addiction

(2016) H. Valerie Curran et al.   NATURE REVIEWS NEUROSCIENCE

Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats

(2016) Daniel I Brierley et al.   PSYCHOPHARMACOLOGY

VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease

(2016) Javier Díaz-Alonso et al.   Scientific Reports

Cannabinoid CB1 Receptors Are Localized in Striated Muscle Mitochondria and Regulate Mitochondrial Respiration

(2016) Juan Mendizabal-Zubiaga et al.   Frontiers in Physiology

Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism

(2016) Isabel González-Mariscal et al.   Scientific Reports

Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users

(2015) Chandni Hindocha et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Δ9 -Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8

(2015) Jessica Margaret Sido et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Association between marijuana use and adverse obstetrical and neonatal outcomes

(2015) C R Warshak et al.   Journal of Perinatology

The Endocannabinoid System and its Modulation by Phytocannabinoids

(2015) Vincenzo Di Marzo et al.   Neurotherapeutics

Molecular Targets of Cannabidiol in Neurological Disorders

(2015) Clementino Ibeas Bih et al.   Neurotherapeutics

Cannabinoids: structures, effects, and classification

(2015) V. A. Shevyrin et al.   RUSSIAN CHEMICAL BULLETIN

PTSD-Like Memory Generated Through Enhanced Noradrenergic Activity is Mitigated by a Dual Step Pharmacological Intervention Targeting its Reconsolidation

(2015) L. Gazarini et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability

(2014) Fabio Arturo Iannotti et al.   ACS Chemical Neuroscience

Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid

(2014) Francesca Borrelli et al.   CARCINOGENESIS

Evaluation of phytocannabinoids from high-potency Cannabis sativa using in vitro bioassays to determine structure–activity relationships for cannabinoid receptor 1 and cannabinoid receptor 2

(2014) Afeef S. Husni et al.   MEDICINAL CHEMISTRY RESEARCH

Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self-Administration in Mice and Rats

(2014) Hai-Ying Zhang et al.   NEUROPSYCHOPHARMACOLOGY

Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice

(2014) Sara Valdeolivas et al.   Neurotherapeutics

Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures

(2014) Sarah Rosenthaler et al.   NEUROTOXICOLOGY AND TERATOLOGY

A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis

(2014) Francisco J. Carrillo-Salinas et al.   PLoS One

Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease

(2013) Francesca Borrelli et al.   BIOCHEMICAL PHARMACOLOGY

Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting inSuncus murinus

(2013) E M Rock et al.   BRITISH JOURNAL OF PHARMACOLOGY

Epigenetic control of skin differentiation genes by phytocannabinoids

(2013) Mariangela Pucci et al.   BRITISH JOURNAL OF PHARMACOLOGY

Involvement of prelimbic medial prefrontal cortex in panic-like elaborated defensive behaviour and innate fear-induced antinociception elicited by GABAA receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei: role of the endocannabinoid CB1 receptor

(2013) Renato Leonardo de Freitas et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses

(2013) S. Sylantyev et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The endocannabinoid signaling system in cancer

(2013) Simona Pisanti et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Endocannabinoid Signaling in Female Reproduction

(2012) Xiaofei Sun et al.   ACS Chemical Neuroscience

Cannabidiolic acid prevents vomiting inSuncus murinusand nausea-induced behaviour in rats by enhancing 5-HT1Areceptor activation

(2012) D Bolognini et al.   BRITISH JOURNAL OF PHARMACOLOGY

A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis

(2012) Aitor G. Granja et al.   Journal of Neuroimmune Pharmacology

Endocannabinoid Signaling and Synaptic Function

(2012) Pablo E. Castillo et al.   NEURON

Why do cannabinoid receptors have more than one endogenous ligand?

(2012) V. Di Marzo et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration

(2012) Shuso Takeda et al.   TOXICOLOGY LETTERS

Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation

(2011) L. De Petrocellis et al.   Acta Physiologica

Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa

(2011) Lucia Renee Ruhaak et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids

(2011) Sharon Anavi-Goffer et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease

(2011) A. M. Martin-Moreno et al.   MOLECULAR PHARMACOLOGY

Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement

(2011) Giuseppe Esposito et al.   PLoS One

TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ9-tetrahydrocannabiorcol

(2011) David A Andersson et al.   Nature Communications

The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice

(2010) Daniele Bolognini et al.   BRITISH JOURNAL OF PHARMACOLOGY

Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes

(2010) Luciano De Petrocellis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds

(2010) Sebastian Dresen et al.   JOURNAL OF MASS SPECTROMETRY

Transient Receptor Potential Ankyrin 1 (TRPA1) Channel as Emerging Target for Novel Analgesics and Anti-Inflammatory Agents

(2010) Pier Giovanni Baraldi et al.   JOURNAL OF MEDICINAL CHEMISTRY

Spice drugs as a new trend: Mode of action, identification and legislation

(2010) I. Vardakou et al.   TOXICOLOGY LETTERS

Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation

(2009) Sumner H. Burstein et al.   AAPS Journal

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors

(2009) TV Zanelati et al.   BRITISH JOURNAL OF PHARMACOLOGY

Species differences in cannabinoid receptor 2 (CNR2gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands

(2009) Q.-R. Liu et al.   GENES BRAIN AND BEHAVIOR

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression

(2009) Sadiye Amcaoglu Rieder et al.   IMMUNOBIOLOGY

‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?

(2009) Volker Auwärter et al.   JOURNAL OF MASS SPECTROMETRY

Cannabinoid Ester Constituents from High-PotencyCannabis sativa

(2008) Safwat A. Ahmed et al.   JOURNAL OF NATURAL PRODUCTS

Antibacterial Cannabinoids fromCannabis sativa: A Structure−Activity Study

(2008) Giovanni Appendino et al.   JOURNAL OF NATURAL PRODUCTS

Plant-Derived Cannabinoids Modulate the Activity of Transient Receptor Potential Channels of Ankyrin Type-1 and Melastatin Type-8

(2008) L. De Petrocellis et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells

(2008) V. L. Hegde et al.   MOLECULAR PHARMACOLOGY

Targeting the endocannabinoid system: to enhance or reduce?

(2008) Vincenzo Di Marzo   NATURE REVIEWS DRUG DISCOVERY

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling

(2007) Joseph Tam et al.   FASEB JOURNAL

Cannabinoid pharmacology: the first 66 years

(2006) Roger G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY